Expense Reimbursement Services are designed to meet legislation of Ukraine and EU Clinical Trial Directive (2001/20/EC) and Regulation (536/2014) that states: no incentives or financial inducements are given to incapacitated participants or minors (or either of their legally designated representatives), or to pregnant women, except for compensation for expenses and loss of earnings directly related to participation in the clinical trial.

While the number of clinical trials in Ukraine increasing and their efficiency and quality as well, patient recruitment and retention becomes more crucial.

The success of the trial depends on identifying the right patients for the study and their further engagement to invest their time and effort into drug development. Patient recruitment is considered to be one of the most difficult challenges and it is estimated that 80% of clinical trials do not meet their patient enrolment deadlines.